MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and mortal cancer, characterized by a set of known mutations, invasive features, and aberrant microRNA expression that have been associated with hallmark malignant properties of PDAC. The lack of effective PDAC treatment options prompted...

Descripción completa

Detalles Bibliográficos
Autores principales: Passadouro, Marta, Pedroso de Lima, Maria C, Faneca, Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086670/
https://www.ncbi.nlm.nih.gov/pubmed/25061297
http://dx.doi.org/10.2147/IJN.S64456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086670/
https://www.ncbi.nlm.nih.gov/pubmed/25061297
http://dx.doi.org/10.2147/IJN.S64456

Ejemplares similares